Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Safety, effectiveness, and cost effectiveness of...
Journal article

Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis

Abstract

OBJECTIVE: To examine the safety, effectiveness, and cost effectiveness of long acting insulin for type 1 diabetes. DESIGN: Systematic review and network meta-analysis.

Authors

Tricco AC; Ashoor HM; Antony J; Beyene J; Veroniki AA; Isaranuwatchai W; Harrington A; Wilson C; Tsouros S; Soobiah C

Journal

The BMJ, Vol. 349, No. oct01 6,

Publisher

BMJ

Publication Date

October 1, 2014

DOI

10.1136/bmj.g5459

ISSN

0959-8138